CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q3 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $286,000 | +39.5% | 16,747 | +227.5% | 0.03% | -43.1% |
| Q1 2020 | $205,000 | -70.8% | 5,114 | -71.2% | 0.05% | -37.8% |
| Q4 2019 | $702,000 | +24.5% | 17,738 | -70.7% | 0.08% | +30.2% |
| Q2 2019 | $564,000 | -55.6% | 60,622 | -33.7% | 0.06% | -51.2% |
| Q1 2019 | $1,270,000 | +8.0% | 91,400 | -15.2% | 0.13% | -5.1% |
| Q4 2018 | $1,176,000 | -43.5% | 107,800 | -34.6% | 0.14% | +18.3% |
| Q3 2018 | $2,083,000 | +152.2% | 164,800 | +162.8% | 0.12% | +180.5% |
| Q2 2018 | $826,000 | – | 62,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |